SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-320920
Filing Date
2018-11-07
Accepted
2018-11-07 16:13:59
Documents
3
Period of Report
2018-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d618996d8k.htm 8-K 16515
2 EX-99.1 d618996dex991.htm EX-99.1 54560
3 GRAPHIC g618996image00170.jpg GRAPHIC 6646
  Complete submission text file 0001193125-18-320920.txt   81550
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38096 | Film No.: 181166489
SIC: 2834 Pharmaceutical Preparations